Trading Signals: TRVN Stock Price Prediction and Forecast (Thu. Jan. 30, 2014 - Fri. Feb. 17, 2017)(Trevena, Inc.)
| TRVN latest price $7.1300 (1.42%) ($6.7900 - $7.1600) on Fri. Feb. 17, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 3.02% (three month average) | | RSI | 67 | | Latest Price | $7.1300(1.42%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | TRVN declines -1.9% a day on average for past five trading days. | | Weekly Trend | TRVN advances 0.2% a week on average for past two weeks. | | Market Behavior | Growth stock rally for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support TRVN advance at 0% a week (0% probability)
TBT(6%) OIH(19%) (0%) (0%) (0%) | | Factors Impacting TRVN price | TRVN will decline at least -1.51% in a week (0% probabilities).
OIH(19%) TBT(6%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | -1.51% (StdDev 3.02%) | | Hourly BBV | 0 () | | Intraday Trend | 1.6% | | | | | |
|
| Resistance Level | $7.25 | | 5 Day Moving Average | $7.29(-2.19%) | | 10 Day Moving Average | $7.55(-5.56%) | | 20 Day Moving Average | $7.25(-1.66%) | | To recent high | -10.2% | | To recent low | 34.8% | | Market Cap | $907m | | | | | | |
Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA. |